��������ϲ�����

During a trip to Granada, Spain, Karen Houseknecht, Ph.D., professor in the College of Pharmacy, was the invited speaker at an event sponsored by Genyo, an organization devoted to the study of genomic medicine and oncological research.  The event was held at the Granada Technology Park on June 26, 2014.

Houseknecht’s presentation was titled “Unraveling the mechanisms underlying metabolic liabilities of second-generation antipsychotic drugs:  Is it all in your bones?”